High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.

[1]  C. Probert,et al.  Mucins and inflammatory bowel disease , 2000, Postgraduate medical journal.

[2]  J. Belaiche,et al.  Clinical pattern of corticosteroid dependent Crohn's disease , 1998, European journal of gastroenterology & hepatology.

[3]  S. Zhao,et al.  Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. , 1996, Blood.

[4]  Costan,et al.  Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. , 1996, Cancer research.

[5]  V. Dulieu,et al.  Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. , 1996, British journal of rheumatology.

[6]  J. McPartlan,et al.  Folate status of gastrointestinal epithelial cells is not predicted by serum and red cell folate values in replete subjects. , 1996, Gut.

[7]  B. Stewart,et al.  Involvement of MDR1 P‐glycoprotein in multifactorial resistance to methotrexate , 1996, International journal of cancer.

[8]  P. Borst,et al.  Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.

[9]  B. Zanker,et al.  Expression of the multidrug resistance gene MDR-1 in peripheral blood mononuclear cells from cyclosporine-treated renal transplant recipients rejecting their graft. , 1995, Transplantation proceedings.

[10]  P. Munkholm,et al.  Frequency of glucocorticoid resistance and dependency in Crohn's disease. , 1994, Gut.

[11]  L. Johnson,et al.  Physiology of the gastrointestinal tract , 2012 .

[12]  P. Wigler,et al.  Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts. , 1994, Biochimica et biophysica acta.

[13]  M. Ikeguchi,et al.  Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. , 1993, Endocrinology.

[14]  S. Bourgeois,et al.  Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. , 1993, Molecular endocrinology.

[15]  M. Gottesman,et al.  The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi‐drug transporter , 1993, International journal of cancer.

[16]  R. Arceci,et al.  Constitutive expression of multidrug resistance in human colorectal tumours and cell lines. , 1993, British Journal of Cancer.

[17]  C. Feighery,et al.  Flow cytometric analysis of surface major histocompatibility complex class II expression on human epithelial cells prepared from small intestinal biopsies. , 1993, Journal of immunological methods.

[18]  W. Selby.  Current management of inflammatory bowel disease , 1993, Journal of gastroenterology and hepatology.

[19]  S. McClean,et al.  An overview of membrane, cytosolic and nuclear proteins associated with the expression of resistance to multiple drugs in vitro. , 1992, Biochimica et biophysica acta.

[20]  R Hori,et al.  Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. , 1992, The Journal of biological chemistry.

[21]  I. Roninson,et al.  Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. , 1992, Blood.

[22]  S. Hammarström,et al.  Isolation of functionally active intraepithelial lymphocytes and enterocytes from human small and large intestine. , 1992, Journal of immunological methods.

[23]  J. Coon,et al.  Multidrug resistance activity in human lymphocytes. , 1991, Human Immunology.

[24]  W. Tremaine,et al.  6-mercaptopurine therapy in selected cases of corticosteroid-dependent Crohn's disease. , 1991, Mayo Clinic proceedings.

[25]  G. Margison,et al.  Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. , 1991, Cancer research.

[26]  R. DePinho,et al.  Structural and functional analysis of the mouse mdr1b gene promoter. , 1991, The Journal of biological chemistry.

[27]  W. Doe.  The intestinal immune system. , 1989, Gut.

[28]  G. van den Engh,et al.  A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells. , 1989, Cytometry.

[29]  P. Meltzer,et al.  Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Ami,et al.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. , 1989, BMJ.

[31]  J. Bulte,et al.  Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistance , 1988, International journal of cancer.

[32]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[33]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[34]  F. Baas,et al.  Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. , 1993, Pharmacology & therapeutics.

[35]  J. Endicott,et al.  The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.

[36]  I. Pastan,et al.  Expression of a multidrug-resistance gene in human tumors and tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.